The Risk-free usage of TILDREN hasn't been evaluated in horses lower than 4 decades of age. The impact of bisphosphonates about the skeleton of expanding horses has not been analyzed; however, bisphosphonates inhibit osteoclast activity which impacts bone turnover and may have an affect on bone development. Bisphosphonates might cause indication